A Study in Healthy Men to Test Whether Rifampicin Influences the Amount of BI 894416 in the Blood

NCT04060719 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

16

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: BI 894416
DRUG: Rifampicin

Sponsor

Boehringer Ingelheim